BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2517322)

  • 1. Effectiveness of steroid therapy in different stages of membranous nephropathy.
    Fuiano G; Stanziale P; Balletta M; Sepe V; Marinelli G; Comi N; Esposito A; Andreucci VE
    Nephrol Dial Transplant; 1989; 4(12):1022-9. PubMed ID: 2517322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
    Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B
    N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and long-term follow-up of patients with stage II to III idiopathic membranous nephropathy.
    Polenakovik MH; Grcevska L
    Am J Kidney Dis; 1999 Nov; 34(5):911-7. PubMed ID: 10561149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW; Branten AJ; Wetzels JF;
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
    Passerini P; Pasquali S; Cesana B; Zucchelli P; Ponticelli C
    Nephrol Dial Transplant; 1989; 4(6):525-9. PubMed ID: 2507973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
    Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy.
    Cattran DC; Delmore T; Roscoe J; Cole E; Cardella C; Charron R; Ritchie S
    N Engl J Med; 1989 Jan; 320(4):210-5. PubMed ID: 2643046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin therapy of membranous nephropathy: efficacy and safety.
    Palla R; Cirami C; Panichi V; Bianchi AM; Parrini M; Grazi G
    Clin Nephrol; 1991 Mar; 35(3):98-104. PubMed ID: 2032403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.
    Laluck BJ; Cattran DC
    Am J Kidney Dis; 1999 Jun; 33(6):1026-32. PubMed ID: 10352189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Membranous glomerulonephritis].
    Polenaković M
    Srp Arh Celok Lek; 1996; 124 Suppl 1():18-25. PubMed ID: 9102898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A; Hill GS; Montseny JJ; Meyrier A
    Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
    Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
    Prasher PK; Varma PP; Baliga KV
    J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic membranous nephropathy in the elderly.
    Passerini P; Como G; Viganò E; Melis P; Pozzi C; Altieri P; Ponticelli C
    Nephrol Dial Transplant; 1993; 8(12):1321-5. PubMed ID: 8159299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
    Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
    Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membranous nephropathy. Long-term follow-up and association with neoplasia.
    Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB
    Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.